Cheung et al. in a group of patients with ALL (n = 32) and acute myeloid leukemia (AML) (n = 7) observed that circulating serum miR-1 and cTnT are good markers of myocardial injury after anthracyclines with AUC = 0.62 (95%CI: 0.38–0.97) and AUC = 0.62 (95%CI: 0.4–0.84), respectively [61]. This evidence concerns the gene TNNT2 and acute myeloid leukemia.